Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia

Hypertriglyceridemia (HTG) is a prevalent medical condition in patients with cardiometabolic risk factors and is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD), if left undiagnosed and undertreated. Current guidelines identify HTG as a risk-enhancing factor and,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mszar, Reed, Bart, Sarah, Sakers, Alexander, Soffer, Daniel, Karalis, Dean G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962307/
https://www.ncbi.nlm.nih.gov/pubmed/36835917
http://dx.doi.org/10.3390/jcm12041382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962307/
https://www.ncbi.nlm.nih.gov/pubmed/36835917
http://dx.doi.org/10.3390/jcm12041382

Ejemplares similares